Iovance Biotherapeutics Inc (IOVA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.59B
Last updated: Nov 17, 2026 at 11:06 AM ET
Iovance Biotherapeutics Inc (IOVA) Competitors
The companies most similar to Iovance Biotherapeutics are Ionis Pharmaceuticals (IONS), Immunovant (IMVT) and Ideaya Biosciences (IDYA). By market cap, Iovance Biotherapeutics ranks 6th of the 13 companies on this page; Immunovant (IMVT) is the largest at $7.07B.
Peer Comparison
IOVA's revenue growth of 80.1% is above the peer median of 13.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | $3.59B | N/A | 9.1x | -58.2% | N/A | 80.1% | 0.00% |
| Ionis Pharmaceuticals Inc (IONS) | $4.84B | N/A | 4.8x | -56.9% | -29.3% | 54.9% | 0.00% |
| Immunovant Inc (IMVT) | $7.07B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ideaya Biosciences Inc (IDYA) | $3.08B | N/A | 85.5x | 0.0% | N/A | -95.1% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Xencor Inc (XNCR) | $2.78B | N/A | 13.5x | -58.8% | -17.3% | 454.9% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Immunitybio Inc (IBRX) | $6.40B | N/A | 30.3x | 0.0% | -780.5% | 52.3% | 0.00% |
| Enliven Therapeutics Inc. (ELVN) | $3.59B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vericel Corp Ord (VCEL) | $2.91B | 89.8x | 9.1x | 10.3% | N/A | 26.5% | 0.00% |
| Vera Therapeutics Inc (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Viking Therapeutics Inc (VKTX) | $3.73B | N/A | N/A | 0.0% | -61.0% | 0.0% | 0.00% |
| Peer median | $3.45B | 178.2x | 13.5x | 0.0% | -51.4% | 13.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Iovance Biotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California. | IONS competitors |
| Immunovant Inc (IMVT) | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. | IMVT competitors |
| Ideaya Biosciences Inc (IDYA) | IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality... | IDYA competitors |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Xencor Inc (XNCR) | Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed... | XNCR competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Immunitybio Inc (IBRX) | ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose... | IBRX competitors |
| Enliven Therapeutics Inc. (ELVN) | Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare... | ELVN competitors |
| Vericel Corp Ord (VCEL) | Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures... | VCEL competitors |
| Vera Therapeutics Inc (VERA) | Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases... | VERA competitors |
| Viking Therapeutics Inc (VKTX) | Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. | VKTX competitors |
Frequently Asked Questions About IOVA
Who are Iovance Biotherapeutics' main competitors?
The companies most similar to Iovance Biotherapeutics include Ionis Pharmaceuticals (IONS), Immunovant (IMVT), Ideaya Biosciences (IDYA), Viridian Therapeutics (VRDN) and Xencor (XNCR), listed from the closest match.
Who is Iovance Biotherapeutics' biggest competitor?
Immunovant (IMVT) is the largest of the similar companies at $7.07B; Ionis Pharmaceuticals (IONS) is the closest match by business profile, size, sector and industry.
How does IOVA stock compare with its competitors?
IOVA's P/S is 9.1x against a peer median of 13.5x; its net margin is -58.2% against a peer median of 0.0%.
Which of Iovance Biotherapeutics' competitors pays a higher dividend?
Iovance Biotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Iovance Biotherapeutics bigger than its competitors?
No. Iovance Biotherapeutics is 6th by market cap among the 13 companies on this page; the largest is Immunovant (IMVT) at $7.07B.
IOVA pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts